Literature DB >> 26170992

Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines.

Maria C Todd1, Heather M Petty1, Jonathan M King2, Brytanie N Piana Marshall1, Rebecca A Sheller1, Maria E Cuevas1.   

Abstract

Tumor-specific deregulated expression of claudins, integral membrane proteins found in tight junctions (TJs), has indicated a possible role for TJ disruption in cancer progression. The current study demonstrates the marked overexpression of claudin-3 protein in two breast cancer cell lines of metastatic origin (MCF-7 and MDA-MB-415). Immunofluorescence and differential detergent fractionation analyses revealed that, although claudin-3 was primarily localized at cell junctions, it was also detected intracellularly. Similarly, the siRNA-mediated suppression of claudin-3 did not considerably affect its pattern of subcellular distribution relative to mock-transfected cells. However, there appeared to be a preferential loss of claudin-3 signal in the cytoskeletal fraction. Wound-healing assays were conducted to assess the effect of endogenous overexpression versus siRNA-mediated suppression of claudin-3 on cellular motility in MCF-7 cells. Suppression of claudin-3 protein levels resulted in a marked decrease in the rate of cellular motility relative to mock-transfected cells. These findings suggest that overexpression of claudin-3 may be important in disrupting TJ integrity and thus contribute to enhanced cellular motility, a key component of tumor progression.

Entities:  

Keywords:  cell motility; metastasis; tight junctions

Year:  2015        PMID: 26170992      PMCID: PMC4487109          DOI: 10.3892/ol.2015.3160

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  13 in total

1.  Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue.

Authors:  X Y Pan; B Wang; Y C Che; Z P Weng; H Y Dai; W Peng
Journal:  Int J Gynecol Cancer       Date:  2007 Jan-Feb       Impact factor: 3.437

2.  Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Authors:  Punita Dhawan; Amar B Singh; Natasha G Deane; Yiran No; Sheng-Ru Shiou; Carl Schmidt; John Neff; M Kay Washington; R Daniel Beauchamp
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

3.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

4.  The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors.

Authors:  Anna-Mária Tokés; Janina Kulka; Sándor Paku; Miklós Máthé; Csilla Páska; Csaba Lódi; András Kiss; Zsuzsa Schaff
Journal:  Pathol Res Pract       Date:  2005       Impact factor: 3.250

5.  Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity.

Authors:  Rachana Agarwal; Theresa D'Souza; Patrice J Morin
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

6.  Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.

Authors:  Fiona Lanigan; Eadaoin McKiernan; Donal J Brennan; Shauna Hegarty; Robert C Millikan; Jean McBryan; Karin Jirstrom; Goran Landberg; Finian Martin; Michael J Duffy; William M Gallagher
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

7.  Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.

Authors:  Patrick Michl; Claudia Barth; Malte Buchholz; Markus M Lerch; Monika Rolke; Karl-Heinz Holzmann; Andre Menke; Heiko Fensterer; Klaudia Giehl; Matthias Löhr; Gerhard Leder; Takeshi Iwamura; Guido Adler; Thomas M Gress
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

8.  Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

Authors:  Scott L Kominsky; Mustafa Vali; Dorian Korz; Theodore G Gabig; Sigmund A Weitzman; Pedram Argani; Saraswati Sukumar
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer.

Authors:  Gottfried E Konecny; Rachana Agarwal; Gary A Keeney; Boris Winterhoff; Monica Brown Jones; Andrea Mariani; Darren Riehle; Christina Neuper; Sean C Dowdy; He-Jing Wang; Patrice J Morin; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2008-03-07       Impact factor: 5.482

10.  Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.

Authors:  Anna-Mária Tokés; Janina Kulka; Sándor Paku; Agnes Szik; Csilla Páska; Pál Kaposi Novák; László Szilák; András Kiss; Krisztina Bögi; Zsuzsa Schaff
Journal:  Breast Cancer Res       Date:  2005-01-31       Impact factor: 6.466

View more
  16 in total

Review 1.  Non-canonical functions of claudin proteins: Beyond the regulation of cell-cell adhesions.

Authors:  Susan J Hagen
Journal:  Tissue Barriers       Date:  2017-05-19

2.  Localization and pneumococcal alteration of junction proteins in the human alveolar-capillary compartment.

Authors:  Andrea Peter; Diana Fatykhova; Olivia Kershaw; Achim D Gruber; Jens Rueckert; Jens Neudecker; Mario Toennies; Torsten T Bauer; Paul Schneider; Maria Schimek; Stephan Eggeling; Norbert Suttorp; Andreas C Hocke; Stefan Hippenstiel
Journal:  Histochem Cell Biol       Date:  2017-03-01       Impact factor: 4.304

Review 3.  Claudins as biomarkers of differential diagnosis and prognosis of tumors.

Authors:  Olga P Popova; Alla V Kuznetsova; Svetlana Yu Bogomazova; Alexey A Ivanov
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-09       Impact factor: 4.553

4.  Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

Authors:  Lakmini Mudduwa; Harshini Peiris; Shania Gunasekara; Deepthika Abeysiriwardhana; Thusharie Liyanage
Journal:  Breast Cancer (Auckl)       Date:  2017-12-13

5.  Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation.

Authors:  Lianmin Zhang; Yuan Wang; Bin Zhang; Hua Zhang; Meng Zhou; Mei Wei; Qiuping Dong; Yue Xu; Zhaosong Wang; Liuwei Gao; Yanjun Qu; Bowen Shi; Jinfang Zhu; Yuesong Yin; Yulong Chen; Lu Sun; Wei Zhang; Shilei Xu; Guoguang Ying; Changli Wang
Journal:  Oncotarget       Date:  2017-04-04

6.  Comparison of transepithelial resistance measurement techniques: Chopsticks vs. Endohm.

Authors:  Rebecca A Sheller; Maria E Cuevas; Maria C Todd
Journal:  Biol Proced Online       Date:  2017-05-10       Impact factor: 3.244

7.  Targeting claudin-3 suppresses stem cell-like phenotype in nonsquamous non-small-cell lung carcinoma.

Authors:  Lin Ma; Wu Yin; Heliang Ma; Ihab Elshoura; Lan Wang
Journal:  Lung Cancer Manag       Date:  2019-02-26

Review 8.  Tight Junctions and the Tumor Microenvironment.

Authors:  Ellaine Salvador; Malgorzata Burek; Carola Y Förster
Journal:  Curr Pathobiol Rep       Date:  2016-07-01

9.  Longitudinal Claudin Gene Expression Analyses in Canine Mammary Tissues and Thereof Derived Primary Cultures and Cell Lines.

Authors:  Susanne C Hammer; Annegret Becker; Katja Rateitschak; Annika Mohr; Florenza Lüder Ripoli; Silvia Hennecke; Johannes Junginger; Marion Hewicker-Trautwein; Bertram Brenig; Anaclet Ngezahayo; Ingo Nolte; Hugo Murua Escobar
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923

10.  Claudin expression profile in flat wart and cutaneous squamous cell carcinoma in epidermodysplasia verruciformis.

Authors:  Lana Luiza da Cruz Silva; Walmar Roncalli Pereira de Oliveira; Naiura Vieira Pereira; Ilana Halpern; Claudia Kwei-Fong Dai Tanabe; Mayra Servilha Grion Mattos; Mirian N Sotto
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.